Conflicting statements from the Trump administration have made owning biotech stocks feel like a roller-coaster ride in recent weeks, but there are a few stocks I’d happily buy and hold despite the sway of political uncertainty. Shares of Ligand Pharmaceuticals (NASDAQ: LGND), Celldex Therapeutics (NASDAQ: CLDX), and Portola Pharmaceuticals (NASDAQ: PTLA) are looking awfully inexpensive, and incoming catalysts will make owning any one of these companies downright exciting this year.